| December 5, 2000 |
December 5, 2000
Cerus Moves Forward with U.S. Phase III Platelet Pathogen Inactivation Trial Following Monitoring Board Report
|
| December 4, 2000 |
December 4, 2000
Cerus and Baxter Report Interim Phase III Data from the Intercept Plasma System
|
| November 30, 2000 |
November 30, 2000
Cerus Corporation Receives U.S. Patent Covering Pathogen Inactivation in Red Blood Cells.
|
| November 2, 2000 |
November 2, 2000
Cerus U.S. Phase 3 Trial of Plasma Pathogen Inactivation System Moves Forward on Monitoring Board Report
|
| October 25, 2000 |
October 25, 2000
Cerus and Baxter Initiate Phase 1C Clinical Trial for Intercept Red Blood Cell System for Pathogen Inactivation
|
| October 18, 2000 |
October 18, 2000
Cerus Corporation Invites You to Join Its Third Quarter Earnings Conference Call on the Web
|
| October 5, 2000 |
October 5, 2000
Cerus and Baxter Present Detailed European Phase III Results of the Intercept Platelet System.
|
| August 29, 2000 |
August 29, 2000
Cerus Corporation Announces $60 Million Private Placement of Common Stock
|
| August 22, 2000 |
August 22, 2000
Cerus and Baxter Announce Results of European Phase 3 Trial of Their Intercept Platelet System for Pathogen Inactivation
|
| August 17, 2000 |
August 17, 2000
Cerus U.S. Phase 3 Trial of Platelet Pathogen Inactivation System Moves Forward on Monitoring Board Report
|
| July 25, 2000 |
July 25, 2000
Cerus Corporation Announces Second Quarter Results
|
| July 21, 2000 |
July 21, 2000
Cerus Corporation Invites You to Join its Second Quarter Earnings Conference Call on the Web
|
| April 27, 2000 |
April 27, 2000
Cerus Phase 3 Intercept Platelet System Trials Move Forward on Favorable Monitoring Board Report
|
| April 27, 2000 |
April 27, 2000
Cerus Corporation Announces First Quarter Results
|
| April 26, 2000 |
April 26, 2000
Cerus Corporation Invites You to Join Its First Quarter Earnings Conference Call on the Web
|
| February 17, 2000 |
February 17, 2000
Cerus Corporation Completes $25 Million Private Placement of Common Stock
|
| January 27, 2000 |
January 27, 2000
Cerus Continues European Phase 3 Trial of Platelet System After Independent Review of Safety and Efficacy Data
|
| January 27, 2000 |
January 27, 2000
Cerus Corporation Announces Fourth Quarter And Year-End Results
|
| January 25, 2000 |
January 25, 2000
Cerus Corporation CEO Stephen Isaacs talks to The Wall Street Transcript
|